Volume 81, Issue 5 (May 2026)

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway

Open Access 28 May 2026Research Article

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway

Jingyu Li, Hanrui Sun, Jiabin Zhou, Jiayu Shi, Peng Xu, Chen Wang, Chuchu Chen, Pengyang Gu, Xinglin Wang, Qing Gong, Anzhen Xu, Yanbo Li, Qi Lu

Pharmazie 2026, 81(5), 51659; https://doi.org/10.31083/Pharmazie51659

Abstract

Download

100

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells

Open Access 26 May 2026Review

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells

Ruiyuan Zhang, Meiyun Xu, Mansa Li, Manyu Xu, Xi Han, Qiongying Hu

Pharmazie 2026, 81(5), 51559; https://doi.org/10.31083/Pharmazie51559

Abstract

Download

102

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review

Open Access 19 May 2026Review

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review

Siniša Babović, Nikola Denda, Nemanja Maletin, Milica Paut Kusturica, Dragan Zečević, Aleksandar Rašković

Pharmazie 2026, 81(5), 51803; https://doi.org/10.31083/Pharmazie51803

Abstract

Download

116

Comparative In Vitro Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching

Open Access 19 May 2026Research Article

Comparative In Vitro Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching

Frank Karkossa, Sandra Klein

Pharmazie 2026, 81(5), 51859; https://doi.org/10.31083/Pharmazie51859

Abstract

Download

130

Volume 81, Issue 5 (2026)

Download 142

Journal Browser

2026

Forthcoming Issue

Current Issue

Article

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway

Open Access 28 May 2026Research Article

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway

Jingyu Li, Hanrui Sun, Jiabin Zhou, Jiayu Shi, Peng Xu, Chen Wang, Chuchu Chen, Pengyang Gu, Xinglin Wang, Qing Gong, Anzhen Xu, Yanbo Li, Qi Lu

Pharmazie 2026, 81(5), 51659; https://doi.org/10.31083/Pharmazie51659

Abstract

Download

100

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells

Open Access 26 May 2026Review

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells

Ruiyuan Zhang, Meiyun Xu, Mansa Li, Manyu Xu, Xi Han, Qiongying Hu

Pharmazie 2026, 81(5), 51559; https://doi.org/10.31083/Pharmazie51559

Abstract

Download

102

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review

Open Access 19 May 2026Review

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review

Siniša Babović, Nikola Denda, Nemanja Maletin, Milica Paut Kusturica, Dragan Zečević, Aleksandar Rašković

Pharmazie 2026, 81(5), 51803; https://doi.org/10.31083/Pharmazie51803

Abstract

Download

116

Comparative In Vitro Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching

Open Access 19 May 2026Research Article

Comparative In Vitro Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching

Frank Karkossa, Sandra Klein

Pharmazie 2026, 81(5), 51859; https://doi.org/10.31083/Pharmazie51859

Abstract

Download

130